JP-2022511783-A5 -

Dates

Publication Date

20221202

Application Date

20191125

Description

Specific embodiments are as follows: The present invention includes, for example, the following embodiments: [Embodiment 1] A method for designing a substance for the treatment and/or prevention of intolerance diseases, characterized by the following: Using a stable structure corresponding to the substance associated with the intolerance disease as a substance for the treatment and/or prevention of the intolerance disease; and The stable structure corresponding to the aforementioned substance is characterized by being a structure of a substance that exists in a solid state at a high temperature of 500°C or higher. [Embodiment 2] The method according to Embodiment 1, characterized in that the stable structure corresponding to the substance related to the intolerance disease is selected from one or more of the following: (1) A stable structure that corresponds to a substance that causes intolerance disease in living organisms; (2) Stable structures that are substances of the organism itself and correspond to substances related to intolerance diseases; (3) Stable structures that counteract substances that inhibit structures causing intolerance diseases; (4) A stable structure corresponding to a substance containing any one of the substances described in (1) to (3) above. [Embodiment 3] A substance for the treatment and/or prevention of the disease, designed according to the method of Embodiment 1 or 2. [Embodiment 4] A method for preparing a substance for the treatment and/or prevention of intolerance diseases as described in Embodiment 3, characterized in that a stable structure corresponding to the substance is prepared by a high-temperature carbonization method. [Embodiment 5] A method for designing a substance for the treatment and/or prevention of food intolerance disease, characterized by the following: Using a stable structure corresponding to the substance associated with the aforementioned food intolerance disorder as a substance for the treatment and/or prevention of the aforementioned food intolerance disorder; and The stable structure corresponding to the aforementioned substance is characterized by being a structure of a substance that exists in a solid state at a high temperature of 500°C or higher. [Embodiment 6] The method according to Embodiment 1, characterized in that the stable structure corresponding to the substance related to the intolerance disease is selected from one or more of the following: (1) Stable structures that correspond to substances that cause food intolerance diseases in living organisms; (2) Stable structures that are substances of the organism itself and correspond to substances related to food intolerance diseases; (3) Stable structures that counteract substances that inhibit structures causing food intolerance diseases; (4) A stable structure corresponding to a substance containing any one of the substances described in (1) to (3) above. [Embodiment 7] A substance for the treatment and/or prevention of food intolerance disease, designed according to the method of Embodiment 5 or 6. [Embodiment 8] A method for preparing a substance for the treatment and/or prevention of food intolerance disease as described in Embodiment 7, characterized in that a stable structure corresponding to the substance is prepared by a high-temperature carbonization method. [Embodiment 9] A method for designing a substance for the treatment and/or prevention of barley intolerance, characterized as follows: Using a stable structure corresponding to the substance related to the aforementioned barley intolerance as a substance for the treatment and/or prevention of the aforementioned barley intolerance; and The stable structure corresponding to the aforementioned substance is characterized by being a structure of a substance that exists in a solid state at a high temperature of 500°C or higher. [Embodiment 10] The method according to Embodiment 9, characterized in that the stable structure corresponding to a substance related to intolerance disease is selected from one or more of the following: (1) A stable structure that corresponds to a substance that causes barley intolerance in living organisms; (2) A stable structure made of the organism itself that corresponds to the substance related to barley intolerance; (3) Stable structures that counteract substances that inhibit structures causing barley intolerance; (4) A stable structure corresponding to a substance containing any one of the substances described in (1) to (3) above. [Embodiment 11] A substance for the treatment and/or prevention of barley intolerance, designed according to the method of Embodiment 9 or 10. [Embodiment 12] A method for preparing a substance for the treatment and/or prevention of barley intolerance according to Embodiment 11, characterized in that a stable structure corresponding to the substance is prepared by a high-temperature carbonization method. [Embodiment 13] A method for designing a substance for the treatment